PKIのニュース
Parkland Corporation Announces the Results of the 2023 Annual and Special Meeting of Shareholders 2023/05/05 02:01:00 Kwhen Finance
PerkinElmer: Remains A Buy For Long-Term Positioning (NYSE:PKI) 2023/04/26 10:24:40 Seeking Alpha
PerkinElmer remains a good steward of capital and a long-term value creator. Click here to see why PKI stock is a Buy.
Short-read Sequencing Market is Poised to Surge at a CAGR of 18.46% to Reach a Humungous Revenue During Forecast Period of 2023 to 2033 | Latest Data by Future Market Insights, Inc. 2023/04/18 03:30:00 Accesswire
NEWARK, DE / ACCESSWIRE / April 17, 2023 / The Short-Read Sequencing Market size is projected to be valued at US$ 6,322.03 million in 2023 and is expected to rise to US$ 34,401.22 million by 2033. The sales of short-read sequencing are projected to expand at a significant CAGR of 18.46% during the forecast period. The global short-read sequencing market is a notably expanding industry that includes technologies and services that enable high-throughput sequencing of DNA or RNA fragments. Short-read sequencing technologies can produce millions or billions of short DNA or RNA reads, with typical lengths ranging from 50 to 300 base pairs. Drivers and challenges have an impact on market dynamics, which can impact businesses. Find more insights in a sample report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16920 Several key factors are driving the short-read sequencing market, including rising demand for genomic analysis in clinical diagnostics, personalized medicine, drug discovery, and agriculture.
Biomarkers Market Report 2023: Increase in Funds and Grants for Biomarker Research Bolsters Sector 2023/03/15 23:15:00 Kwhen Finance
PerkinElmer Inc. (PKI) Presents at Cowen 43rd Annual Health Care Conference (Transcript) 2023/03/09 16:18:02 Seeking Alpha
PerkinElmer Inc. (NYSE:NYSE:PKI) Cowen 43rd Annual Health Care Conference March 6, 2023 9:10 AM ETCompany ParticipantsMaxwell Krakowiak - CFOConference Call ParticipantsMax Masucci - Cowen…
High-Performance Liquid Chromatography Global Market Report 2022: Ukraine-Russia War Impact 2022/12/20 12:37:00 GlobeNewswire
Major players in the high-performance liquid chromatography market are Waters Corporation, Agilent Technologies Inc, Shimadzu Corporation, Thermo Fisher Scientific Inc, PerkinElmer Inc, General Electric Company, Bio-Rad Laboratories Inc, Merck Millipore, Hitachi High-Technologies Corporation, Showa Denko K K, Gilson Inc, Phenomenex, Jasco Inc, Hamilton Company, Tosoh Corporation, YMC CO LTD, Danaher Corporation, Restek, SIELC Technologies, Trajan Scientific Australia Pty Ltd, Sartorius AG and Mitsubishi Chemical Corporation. Major players in the high-performance liquid chromatography market are Waters Corporation, Agilent Technologies Inc, Shimadzu Corporation, Thermo Fisher Scientific Inc, PerkinElmer Inc, General Electric Company, Bio-Rad Laboratories Inc, Merck Millipore, Hitachi High-Technologies Corporation, Showa Denko K K, Gilson Inc, Phenomenex, Jasco Inc, Hamilton Company, Tosoh Corporation, YMC CO LTD, Danaher Corporation, Restek, SIELC Technologies, Trajan Scientific Australia Pty Ltd, Sartorius AG and Mitsubishi Chemical Corporation.
KeyBanc Upgrades PerkinElmer to Overweight 2022/12/19 08:43:10 Investing.com
https://www.investing.com/news/pro/keybanc-upgrades-perkinelmer-to-overweight-432SI-2966925
Global Microarray Market Report 2022-2028: Rising Use of Microarrays to Diagnose Infectious Diseases Fuels Growth - ResearchAndMarkets.com 2022/12/16 11:01:00 Kwhen Finance
Global Pre-clinical Imaging Market Report to 2029 - Featuring Bruker, Siemens, General Electric and TriFoil Imaging Among Others - ResearchAndMarkets.com 2022/12/14 10:35:00 Kwhen Finance
PerkinElmer upgraded at Cowen on profitability potential 2022/12/06 21:08:25 Investing.com
https://www.investing.com/news/stock-market-news/perkinelmer-upgraded-at-cowen-on-profitability-potential-432SI-2958551
Cowen Upgrades PerkinElmer to Outperform 2022/12/06 08:25:02 Investing.com
https://www.investing.com/news/pro/cowen-upgrades-perkinelmer-to-outperform-432SI-2957939